MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$40,643,468
EPS
-$0.7
Unit: Dollar
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue
-
-
0
-
Research and development
28,866,292
27,376,912
23,132,671
20,359,098
General and administrative
14,079,328
9,395,941
6,023,337
5,924,942
Total operating expenses
42,945,620
36,772,853
29,156,008
26,284,040
Loss from operations
-42,945,620
-36,772,853
-29,156,008
-26,284,040
Other income (loss)
2,271
8,145
11,205
6,740
Investment income
2,211,295
2,904,506
2,021,214
1,713,499
Interest expense
-
-
3,124,484.5*
-
Gain on disposal of fixed assets
-
-81,143
78,759.5*
-6,846
Total other income (expense)
2,213,566
2,831,508
-1,013,306
1,713,393
Loss before income taxes
-40,732,054
-33,941,345
-30,170,514*
-
(provision for) benefit from income taxes
1,600
-
400*
-
Net loss
-40,733,654
-33,941,345
-30,170,914
-24,570,647
Net unrealized gain (loss) on marketable securities
90,186
-536,881
-560,968
-543,452
Comprehensive loss
-40,643,468
-34,478,226
-30,731,882
-25,114,099
Basic EPS
-0.7
-0.59
-0.629
-0.54
Diluted EPS
-0.7
-0.59
-0.629
-0.54
Basic Average Shares
57,926,347
57,434,267
48,851,809
45,716,151
Diluted Average Shares
57,926,347
57,434,267
48,851,809
45,716,151
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$40,643,468 (-54.33%↓ Y/Y)Net unrealized gain(loss) on marketable...$90,186 (121.25%↑ Y/Y)Net loss-$40,733,654 (-57.21%↓ Y/Y)Investment income$2,211,295 (23.31%↑ Y/Y)Other income (loss)$2,271 (-84.85%↓ Y/Y)Loss before incometaxes-$40,732,054 (provision for) benefitfrom income taxes$1,600 Total other income(expense)$2,213,566 (22.41%↑ Y/Y)Loss from operations-$42,945,620 (-54.93%↓ Y/Y)Total operatingexpenses$42,945,620 (54.93%↑ Y/Y)Research and development$28,866,292 (30.93%↑ Y/Y)General andadministrative$14,079,328 (148.23%↑ Y/Y)

CAPRICOR THERAPEUTICS, INC. (CAPR)

CAPRICOR THERAPEUTICS, INC. (CAPR)